AlloVir News

AlloVir | PRE 14A: Preliminary proxy statements relating to merger or acquisition

16:38 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Hagen Brett R

Nov 20 16:18 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Sinha Vikas

Nov 20 16:17 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Miller Edward

Nov 20 16:17 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Brainard Diana

Nov 20 16:17 ET

AlloVir | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 19 20:01 ET

AlloVir | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 19 20:01 ET

AlloVir | 10-Q: Q3 2024 Earnings Report

Nov 12 16:03 ET

AlloVir | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 8 16:20 ET

AlloVir | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 8 16:17 ET

AlloVir | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 8 16:16 ET

AlloVir | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 8 16:13 ET

AlloVir | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 8 16:12 ET

AlloVir | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 8 08:35 ET

AlloVir | 8-K: Current report

Nov 8 08:30 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Brainard Diana

Nov 6 16:20 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Miller Edward

Nov 6 16:20 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Hagen Brett R

Nov 6 16:20 ET

AlloVir | 4: Statement of changes in beneficial ownership of securities-Officer Sinha Vikas

Nov 6 16:17 ET

AlloVir | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 5 20:01 ET